Full Professor
Strategic program(s):
Biography
Niels Eijkelkamp (18-07-1980) is PI at the laboratory of translational immunology. His research focusses on chronic pain, a major debilitating disease that affects >20% of the population. He aims to unravel mechanisms and to identify novel treatments of chronic pain by elucidating the role of the immune system and its interactions with the nervous system in chronic pain. His group is one of the very few groups in the Netherlands studying the mechanisms underlying pain.
His group uses different experimental approaches to unravel molecular pain mechansims and identify novel treatment approaches with the ultimate aim to translate these basic research findings to chronic pain patients such as children with Juvenile Idiopathic arthritis and adults with chronic inflammatory disease and osteoarthtis.
Eijkelkamp graduated in 2003 with honors in Medical Biology (University of Utrecht). In 2009 he completed his PhD under supervision of Dr. Heijnen with his thesis entitled ‘GRK gatekeeper of pain and inflammation’. Prior to his PhD he worked for 1 year on stress and wound healing in the team led by Dr. Sheridan at the Ohio State University. As PostDoc he had a joint appointment at the UMCU and University of Illinois at Urbana-Champaign to work on the role of GRKs in pain. Finally, he worked for 2 years on sensory transduction and signalling pathways in chronic pain in the laboratory of Dr. Wood at the University College London. Since 2013 he started his own group at the UMCU.
Research aim
Our group aims to integrate fundamental research and clinical pain studies with a focus on neuroinflammation to design strategies preventing and reversing the transition from acute to chronic pain in patients.Research aim
Our research groups integrate fundamental research and clinical pain studies to understand the neurobiology of chronic pain. We focus on the interactions between the immune system and the nervous system to defeat chronic pain.Research aim
Our group studies osteoarthritis, from disease mechanisms to treatment strategies. Using a translational approach, we connect lab research to patient care, aiming to create effective diagnostic tools and patient-centered therapies.2007: G protein-coupled receptor kinase 6 controls post-inflammatory visceral hyperalgesia in mice
Consultant en een founder van de Synerkine founders BV - Consultancy - Synerkine Pharma
Vice-chair of the scientific advisory board of Stichting MS Research - Independent vice chair; advise the board of on scientific matters, including proposals - Stichting MS research
Occasional, ad hoc, Consultancy (Moebius, petalouda therapeutics, Ono pharmaceuticals) - Consultancy with regard to the topic of NeuroImmunology of pain - Various
